Evercore ISI Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $30.00

Privia Health Group (NASDAQ:PRVA) had its price target upped by equities researchers at Evercore ISI from $28.00 to $30.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of 28.04% from the stock’s previous close.

A number of other equities analysts have also issued reports on PRVA. Citizens Jmp upped their target price on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research report on Friday. Barclays lifted their price target on shares of Privia Health Group from $21.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 9th. Piper Sandler cut their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Citigroup reissued an “outperform” rating on shares of Privia Health Group in a report on Friday, August 29th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Privia Health Group in a research note on Wednesday, October 8th. Twelve equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.25.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $23.43 on Friday. The firm has a 50-day moving average of $24.15 and a two-hundred day moving average of $22.77. The stock has a market cap of $2.88 billion, a P/E ratio of 180.24, a PEG ratio of 3.20 and a beta of 0.83. Privia Health Group has a 1-year low of $18.77 and a 1-year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The business had revenue of $213.61 million for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. As a group, equities analysts expect that Privia Health Group will post 0.14 earnings per share for the current year.

Institutional Investors Weigh In On Privia Health Group

Several institutional investors and hedge funds have recently bought and sold shares of the business. Strs Ohio bought a new position in Privia Health Group in the 1st quarter worth approximately $849,000. State of Alaska Department of Revenue raised its stake in Privia Health Group by 9.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 62,406 shares of the company’s stock valued at $1,435,000 after acquiring an additional 5,223 shares in the last quarter. Yousif Capital Management LLC boosted its position in Privia Health Group by 2.5% during the 2nd quarter. Yousif Capital Management LLC now owns 39,687 shares of the company’s stock worth $913,000 after acquiring an additional 955 shares during the period. Teacher Retirement System of Texas bought a new position in shares of Privia Health Group in the first quarter worth $387,000. Finally, Cerity Partners LLC grew its stake in shares of Privia Health Group by 122.1% in the first quarter. Cerity Partners LLC now owns 25,821 shares of the company’s stock worth $580,000 after purchasing an additional 14,195 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.